EverydayHealth

This week’s Research Roundup highlights carcinoid heart disease in patients with bronchopulmonary carcinoid.

Joseph Maleszewski, M.D., Consultant in the Division of Anatomic Pathology in the Department of Laboratory Medicine and Pathology (DLMP) at Mayo Clinic in Rochester, Minnesota, and Melanie Bois, M.D., Senior Associate Consultant in the Division of Anatomic Pathology in DLMP at Mayo Clinic, are featured on the Top 100 "Power List" from The Pathologist.

Kylie Reising, a student in the Mayo Clinic Medical Laboratory Science program, discusses her journey from undergrad to the MLS program.

On the September 22 broadcast of Mayo Clinic Radio, Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic and Chair of the Cellular Therapeutics Cross-Disciplinary Group in the Mayo Clinic Cancer Center, explained how chimeric antigen receptor T-cell therapy (CAR T-cell therapy) works and where the research is headed.

In a recent Q&A in CAP Today, Mohamed Salama, M.D., Medical Director of Mayo Medical Laboratories, discusses the use of CD30 as a predictive marker for therapy.

This week’s Research Roundup highlights the limitations of platform assays to measure serum 25OHD level impact on guidelines and practice decision-making.

Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic and Chair of the Cellular Therapeutics Cross-Disciplinary Group in the Mayo Clinic Cancer Center, spoke at the Individualizing Medicine Conference, "Advancing Care through Genomics," on CAR T-cell therapy. In this new cancer treatment, T cells are genetically modified to equip them to recognize and destroy cancer cells.

Aziza Nassar, M.D., was selected as the new Chair of the Florida Division of Laboratory Medicine. She will enter the role on September 19.

S. Vincent Rajkumar, M.D., has received the 2018 Distinguished Mayo Clinic Investigator Award. The Distinguished Mayo Clinic Investigator Award is presented to individuals whose research careers demonstrate evidence of great distinction, high distinguished scholarship, creative achievement, and excellence in education and administrative responsibilities.

Newly discovered BRCA1 mutations known as “variants of unknown significance” (or VUS) could be harmful, making a woman’s risk of developing breast cancer as high as 72%. Fergus Couch, Ph.D., Chair of the Division of Experimental Pathology and Laboratory Medicine at Mayo Clinic, discusses the issue.

Kevin Halling, M.D., Ph.D., a Consultant in Mayo Clinic's Division of Laboratory Genetics and Genomics, spoke at the Individualizing Medicine Conference: Advancing Care through Genomics, on RNA sequencing.

Ciara Dollar, a student in the Mayo Clinic Medical Laboratory Science program, provides a quick snapshot of what life in the program is like.

Keith Stewart, M.B., Ch.B., Carlson and Nelson Endowed Director, Mayo Clinic Center for Individualized Medicine, presented six ways precision medicine has further advanced into patient care over the past year.